While progression of cardiac disease is thus a feature of T2D, it may in some cases go undetected due to atypical symptom presentation or so-called silent manifestations [152, 153], in the proposed unrecognised diabetic cardiac impairment phenomenon [48]
Mol Ecol 28(13):31973207 [DOI] [PMC free article] [PubMed] [Google Scholar] Tanase DM, Gosav EM, Neculae E, Costea CF, Ciocoiu M, Hurjui LL, Tarniceriu CC, Floria M (2020) Hypothyroidism-induced nonalcoholic fatty liver disease (HIN): mechanisms and emerging therapeutic options
It plays a critical role in how your body handles food and insulin
Read the full story here - #FDAApproval #HeartFailure #LasixOnyu #MedicalInnovation #CardiologyNews #PharmaUpdate #HealthcareTechnology #PatientCare #MedtigoNews #DrugApproval #MedicalCommunity #HealthcareInnovation #ClinicalUpdates #Furosemide #DigitalHealth #HomeTreatment #medtigo To view or add a comment, sign in #MoleculeMonday: Thalidomide was once a global tragedy